The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments
Clinical Cardiology · 2023
DOI: 10.1002/clc.24022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, 2023. Verfasst von Hossein Salehi Omran und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Defibrillators, Implantable. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with nonischemic dilated cardiomyopathy (DCM) are susceptible to arrhythmias and implantable cardioverter defibrillator (ICD) in addition to medical treatments may help prevent sudden cardiac death (SCD) and improve survival in this population. Hypothesis We aim to investigate the impact of ICD insertion on survival and prognosis of patients with nonischemic DCM.
Methods
We retrospectively analyzed data from patients with nonischemic DCM treated with medical therapy with or without ICD who referred to our hospital from January 2020 to November 2021. Patients were divided based on the treatment that they had received into two equal groups. Different variables including demographic features, comorbidities, medical treatments, hospitalization rate, function class, and left ventricular ejection fraction before and after treatments were investigated in this study. In addition, variables in survival including overall survival (OS) and SCD were compared between the two groups.
Results
A total of 120 patients were investigated in this study. Mean ± SD of age and follow‐up time of patients were 64.0 ± 12.7 years old and 61.2 ± 15.9 months, respectively. Ten (16.7%) patients with medical therapy, and seven (11.7%) patients with ICD and medical therapy died during the follow‐up period ( p = 0.25). However, the two groups had a significant difference regarding SCD (11.7% vs. 1.7%, p = 0.02).
Conclusion
In patients with nonischemic DCM who had undergone ICD insertion in addition to standard medical treatments, SCD was significantly reduced compared with patients receiving just medical treatments. OS had no significant difference between our two studied groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
- Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Burn Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Cardiology Department, Rohani Hospital, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
- Department of Cardiology, Babol University of Medical Sciences, Babol, Iran.
Zitieren
APA
Salehi Omran, H., Naghashzadeh, F., Irilouzadian, R., Dolatshahi, S., Hedayati Goudarzi, M. T., & Salehi Omran, M. T. (2023). The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments. Clinical Cardiology. https://doi.org/10.1002/clc.24022
Vancouver
Salehi Omran H, Naghashzadeh F, Irilouzadian R, Dolatshahi S, Hedayati Goudarzi MT, Salehi Omran MT. The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments. Clinical Cardiology. 2023. doi:10.1002/clc.24022
BibTeX
@article{SalehiOmran2023,
author = {Salehi Omran, Hossein and Naghashzadeh, Farah and Irilouzadian, Rana and Dolatshahi, Sina and Hedayati Goudarzi, Mohammad Taghi and Salehi Omran, Mohammad Taghi},
title = {The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments},
journal = {Clinical Cardiology},
year = {2023},
doi = {10.1002/clc.24022}
}
EUVIMED